Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma

by Chng, W.-J., Huang, G.F., Chung, T.H., Ng, S.B., Gonzalez-Paz, N., Troska-Price, T., Mulligan, G., Chesi, M., Bergsagel, P.L., Fonseca, R.
Published 2014

Role of Pirh2 in mediating the regulation of p53 and c-Myc

by Hakem A., Bohgaki M., Lemmers B., Tai E., Salmena L., Matysiak-Zablocki E., Jung Y.-S., Karaskova J., Kaustov L., Duan S., Madore J., Boutros P., Sheng Y., Chesi M., Bergsagel P.L., Perez-Ordonez B., Mes-Masson A.-M., Penn L., Squire J., Chen X., Jurisica I., Arrowsmith C., Sanchez O., Benchimol S., Hakem R.
Published 2020